文献速递造血干细胞移植与细胞治疗

调节性T细胞促进晚孕期宫内造血细胞移植模型中的异体植入

Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.
PubMed 文献 · Blood Adv · 2020-01-01

该研究在小鼠晚孕期宫内造血细胞移植(IUHCT)模型中探索调节性T细胞(Treg)的作用。结果显示,从IUHCT耐受或naive小鼠获取的Treg富集移植物在20 DPC(性交后天数)植入频率与14 DPC未富集移植物相当,且实现长期多系供体细胞嵌合、无GVHD或死亡,受体T细胞同种反应性降低。提示供体移植物富集Treg可在妊娠后期成功实施IUHCT。

要点

  • Treg富集移植物在20 DPC植入频率与14 DPC未富集移植物相当
  • 实现长期多系供体细胞嵌合,无GVHD或死亡
  • 受体T细胞同种反应性降低,符合供体特异性耐受

核心结论

  • 供体移植物富集调节性T细胞可在小鼠晚孕期IUHCT模型中促进异体植入并维持同种移植物耐受。

研究设计与样本

  • 小鼠晚孕期IUHCT模型,比较Treg富集移植物在20 DPC与未富集移植物在14 DPC的植入情况。

主要发现

  • Treg富集移植物(来自IUHCT耐受或naive小鼠)在20 DPC的植入频率与14 DPC未富集移植物相等。
  • 实现长期多系供体细胞嵌合,无移植物抗宿主病或死亡。
  • 观察到受体T细胞同种反应性降低,符合供体特异性耐受。

临床怎么用

  • 提示供体移植物富集Treg可能使IUHCT在妊娠后期实施成为可能。

局限性

  • 证据来自小鼠模型,尚未在人类中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In utero hematopoietic cell transplantation (IUHCT) has the potential to cure congenital hematologic disorders including sickle cell disease. However, the window of opportunity for IUHCT closes with the acquisition of T-cell immunity, beginning at approximately 14 weeks gestation, posing significant technical challenges and excluding from treatment fetuses evaluated after the first trimester. Here we report that regulatory T cells can promote alloengraftment and preserve allograft tolerance after the acquisition of T-cell immunity in a mouse model of late-gestation IUHCT. We show that allografts enriched with regulatory T cells harvested from either IUHCT-tolerant or naive mice engraft at 20 days post coitum (DPC) with equal frequency to unenriched allografts transplanted at 14 DPC. Long-term, multilineage donor cell chimerism was achieved in the absence of graft-versus-host disease or mortality. Decreased alloreactivity among recipient T cells was observed consistent with donor-specific tolerance. These findings suggest that donor graft enrichment with regulatory T cells could be used to successfully perform IUHCT later in gestation.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Riley JS, McClain LE, Stratigis JD, et al. Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation. Blood Adv. 2020. PMID: 32203584. doi:10.1182/bloodadvances.2019001208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。